drugset / Trial / NCT06901245
Tirzepatide in PWS, HO and GNSO
Phase 4
Recruiting
36 enrolled
Grace Kim
Children's Hospitals and Clinics of Minnesota · collabSeattle Children's Hospital · collabVanderbilt University Medical Center · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This research study is comparing the effectiveness of a weight loss medication called Tirzepatide in young adults with Prader-Willi Syndrome and/or hypothalamic obesity, as compared to young adults with obesity that is unrelated to a genetic syndrome or underlying medical cause. These groups will be given medication for 1 year to see how weight and other health factors are effected by the medication.
Timeline
- Start
- 2025-05-01
- Primary completion
- 2026-06
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tirzepatide | Peptide | — | — |